-
-
Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
-
-
Statin Use After Diagnosis of Colon Cancer and Patient Survival
-
-
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
-
-
The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
-
-
Prognostic and predictive biomarkers in colorectal cancer. Towards precision medicine
-
-
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients (vol 110, pg 459, 2014)
-
-
The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients
-
-
Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and II Rectal Cancer Patients
-
-
OPINION How does genome sequencing impact surgery?
-
-
Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray
-
-
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
-
-
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
-
-
Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
-
-
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
-
-
COX-2 expression influences the prognostic effect of aspirin use after diagnosis in colon cancer patients
-
-
The diagnostic value of one step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer
-
-
Aspirin use after diagnosis improves survival in older adults with colon cancer: a retrospective cohort study
-
-
Aspirin use after the diagnosis improves survival in older colon cancer patients: a retrospective cohort study
